BeOne launches corporate campaign “One Save Changes Everything”
BeOne has launched the corporate campaign “One Save Changes Everything”, spotlighting decisive moments in cancer care and its focus on access and development.
BeOne has launched the corporate campaign “One Save Changes Everything”, spotlighting decisive moments in cancer care and its focus on access and development.
Vetter has started construction of a new production site in Saarlouis. The first phase includes a 50,000 m² building, with start-up planned for 2031.
Angelini Pharma has agreed to buy Catalyst for $4.1bn in cash, entering the U.S. market. The companies expect the deal to close in Q3 2026.
UEFA has named Haleon its first partner for medicine and health. The multi-year collaboration focuses on evidence-based pain management in football.
Friso Janßen has been appointed CEO of the German Heart Foundation effective 4 May 2026, succeeding Martin Vestweber and focusing on prevention and research.
GSK has recruited Julie Bowen and Ty Burrell for its Ask2BSure initiative, spotlighting meningitis risks and vaccination gaps in 16 to 23-year-olds.
Eli Lilly has partnered with basketball player Caitlin Clark to promote prevention messaging, including exercise and breast cancer early detection awareness.
Robin Gosens’ mental health podcast “Wie geht’s?” is moving to ARD, with ARD Gesund and N-JOY taking editorial responsibility for the format.
Sanofi has confirmed Belén Garijo as CEO from May 1, 2026. Shareholders also approved a dividend of €4.12 per share, payable May 7.
Roche has signed a definitive deal to acquire PathAI. The move is aimed at strengthening digital pathology and AI-enabled diagnostic capabilities.